These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 38145889

  • 1. A strategy for the detection of benzodiazepine drugs using low-resolution paper-spray mass spectrometry for harm reduction drug checking.
    Miskulin A, Wallace B, Gill C, Hore D.
    Drug Test Anal; 2024 Oct; 16(10):1085-1093. PubMed ID: 38145889
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A new quantitative drug checking technology for harm reduction: Pilot study in Vancouver, Canada using paper spray mass spectrometry.
    Borden SA, Saatchi A, Vandergrift GW, Palaty J, Lysyshyn M, Gill CG.
    Drug Alcohol Rev; 2022 Feb; 41(2):410-418. PubMed ID: 34347332
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of three unexpected new psychoactive substances at an Australian drug checking service.
    Algar JL, Lawes DJ, Carroll AJ, Caldicott D, McLeod MD.
    Drug Test Anal; 2024 Oct; 16(10):1144-1154. PubMed ID: 38205685
    [Abstract] [Full Text] [Related]

  • 9. Implementation of a community-based LC-UV drug checking service: promising preliminary findings on feasibility and validity.
    Fabresse N, Papias E, Heckenroth A, Martin V, Allemann D, Roux P.
    Harm Reduct J; 2024 Oct 18; 21(1):185. PubMed ID: 39425213
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rapid analysis of fentanyls and other novel psychoactive substances in substance use disorder patient urine using paper spray mass spectrometry.
    Kennedy JH, Palaty J, Gill CG, Wiseman JM.
    Rapid Commun Mass Spectrom; 2018 Aug 15; 32(15):1280-1286. PubMed ID: 29757475
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Variability in the unregulated opioid market in the context of extreme rates of overdose.
    Larnder A, Saatchi A, Borden SA, Moa B, Gill CG, Wallace B, Hore D.
    Drug Alcohol Depend; 2022 Jun 01; 235():109427. PubMed ID: 35405459
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Beyond a spec: assessing heterogeneity in the unregulated opioid supply.
    Gozdzialski L, Louw R, Kielty C, Margolese A, Poarch E, Sherman M, Cameron F, Gill C, Wallace B, Hore D.
    Harm Reduct J; 2024 Mar 15; 21(1):63. PubMed ID: 38491435
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.